Showing results (81-90 of 210) with videos related to
Sort By:
Pageof 21
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2021
SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastomaJacqueline A Brosnan-Cashman, Christine M Davis, Bill H Diplas, et al.Biorxiv : the Preprint Server for Biology|January 23, 2026
Beyond Cell Cycle Control: <i>CDKN2A</i> Loss Orchestrates NAD <sup>+</sup> Metabolic Plasticity and NAMPT Inhibitor Sensitivity in GlioblastomaSwati Dubey, Guanqiao Yu, Ryana Aboul-Hosn, et al.Cancer Research|October 9, 2020
Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Amy N Allen, et al.Journal of Neuropathology and Experimental Neurology|September 21, 2020
Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic FindingsMeaghan Morris, Meghan Driscoll, John W Henson, et al.Acta Neuropathologica Communications|November 21, 2013
Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytomaCristiane M Ida, Julie A Vrana, Fausto J Rodriguez, et al.World Neurosurgery|January 22, 2021
Predictors of Postoperative Visual Outcome After Surgical Intervention for CraniopharyngiomasSrujan Kopparapu, Adham M Khalafallah, David Botros, et al.The American Journal of Surgical Pathology|May 9, 2014
Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patientsFausto J Rodriguez, Tarik Tihan, Doris Lin, et al.The American Journal of Surgical Pathology|August 24, 2017
BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic CharacteristicsNooshin Karamzadeh Dashti, Armita Bahrami, Seung J Lee, et al.Neuro-Oncology|September 22, 2023
Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translationTill Milde, Jason Fangusaro, Michael J Fisher, et al.Disease Models & Mechanisms|February 14, 2024
Stem cell modeling of nervous system tumorsFrank B Furnari, Corina Anastasaki, Shan Bian, et al.Pageof 21